Devices
Baxter De Novo Granted for Theranova Dialysis Membrane
FDA has granted Baxter International a de novo application for the Theranova dialysis membrane. The company says the device was designed to deliver expanded hemodialysis therapy, which filters a wider range of molecules from the blood than traditional hemodialysis filters, like high-flux membranes, by “targeting effective removal of conventional